AI news impact · US stocks
Johnson & Johnson (JNJ) news impact
On 2026-11-02 Wave Radar's AI rated the news on Johnson & Johnson as neutral (impact score 0%).
Provided news consists of broader pharmaceutical peer earnings previews and dividend stock commentary, without material updates specific to Johnson & Johnson.
- Direction
- Neutral
- Impact score
- 0%
- Confidence
- 50%
- Headlines read
- 3
- Date
- 2026-11-02
AI assessment
Without direct company-specific developments or operational disclosures, the overall impact on Johnson & Johnson remains neutral.
Sector impact
Routine broad industry commentary with no discernible spillover effect on the pharmaceutical sector.
Headlines the AI read
- Will These 5 Drug Bigwigs Surpass Q3 Earnings Forecasts? Yahoo Finance/JNJ · 2026-11-02
- Intuitive Surgical Stock Just Fell Despite a 22% Revenue Jump. Here's What Investors Are Missing. Yahoo Finance/JNJ · 2026-11-01
- 5 Most Undervalued Dividend Growth Stocks According to Hedge Funds Yahoo Finance/JNJ · 2026-11-01
Rating history
One rating per trading day the stock was covered.
More on Johnson & Johnson
How the rating works
After each close Wave Radar collects the day's headlines and filings for a stock and asks an AI model what they mean for it. The rating is one of five levels from major negative to major positive; the impact score runs from −100% to +100%, and a rating built on a single uncorroborated source is capped. It describes the news, not the price outlook.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.